Hero image with Pittsburgh background https://pittplusme.org/study/2418

STUDY BASICS

Have you been diagnosed with moderate to severe bullous pemphigoid? You may be eligible to participate in a research study to investigate a potential treatment for bullous pemphigoid. Compensation provided.


STUDY PURPOSE

The purpose of this study is to evaluate the safety and effectiveness of an investigational study drug in bullous pemphigoid patients.


COULD THIS STUDY BE RIGHT FOR YOU?
  • You have been diagnosed with moderate to severe bullous pemphigoid (BP)
  • You have active blisters in multiple places or large blisters that cause you discomfort
  • You have been taking or are taking oral prednisone and immunosuppressants but still have active blisters

WHAT PARTICIPANTS CAN EXPECT
  • Screening period: 2-3 weeks
  • Treatment period:  36 weeks
  • Follow-up period: 7 weeks

 


IRB: CR00406791
- argenx BV - ARGX-113-2009, A Phase 2/3, Randomized, Double-Blinded, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (BALLAD) (Pro00059941)

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/2418 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe